Clinical Efficacy and Safety of Mesenchymal Stem Cells for Systemic Lupus Erythematosus
Systemic lupus erythematosus (SLE) is a polymorphic, multisystemic autoimmune disease that causes multiorgan damage in which cellular communication occurs through the involvement of autoantibodies directed against autoantigen production. Mesenchymal stem cells (MSCs), which have strong protective an...
Saved in:
Main Authors: | Tianbiao Zhou (Author), Hong-Yan Li (Author), Chunling Liao (Author), Wenshan Lin (Author), Shujun Lin (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nephroprotective Effect of Mesenchymal Stem Cell-Based Therapy of Kidney Disease Induced by Toxicants
by: Shujun Lin, et al.
Published: (2020) -
The Efficacy of Mesenchymal Stem Cells in Therapy of Acute Kidney Injury Induced by Ischemia-Reperfusion in Animal Models
by: Tianbiao Zhou, et al.
Published: (2020) -
An Overview of the Safety, Efficiency, and Signal Pathways of Stem Cell Therapy for Systemic Lupus Erythematosus
by: Qian Yang, et al.
Published: (2021) -
Multitarget Therapy: An Effective and Safe Therapeutic Regimen for Lupus Nephritis
by: Tianbiao Zhou, et al.
Published: (2019) -
Relationship between TGF-β1 + 869 T/C and + 915 G/C gene polymorphism and risk of acute rejection in renal transplantation recipients
by: Hong-Yan Li, et al.
Published: (2019)